Search: WFRF:(Sundin Anders)
> (2010-2014) >
11C-metomidate posi...
11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism
-
- Hennings, Joakim, 1969- (author)
- Uppsala universitet,Endokrinkirurgi,Hellman/Endokrinkirurgi
-
- Sundin, Anders (author)
- Karolinska Institutet,Uppsala universitet,Enheten för radiologi
-
- Hägg, Anders (author)
- Uppsala universitet,Institutionen för medicinska vetenskaper
-
show more...
-
- Hellman, Per (author)
- Uppsala universitet,Endokrinkirurgi
-
show less...
-
(creator_code:org_t)
- 2010-07-20
- 2010
- English.
-
In: Langenbeck's archives of surgery (Print). - : Springer Science and Business Media LLC. - 1435-2443 .- 1435-2451. ; 395:7, s. 963-967
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Purpose: To evaluate whether dexamethasone suppression treatment can improve 11 C-metomidate positron emission tomography (MTO-PET) detection of small adrenocortical adenomas in primary aldosteronism (PA). Materials and Methods: Eleven patients with proven PA and two patients with non-hyperfunctioning adrenocortical incidentalomas and small adrenocortical tumours observed on CT underwent MTO-PET before and 3 days after administration of oral dexamethasone suppression treatment. Small “hot-spot” regions of interest (ROIs) comprising 4-pixels (SUVhs) and 1-pixel (SUVmax) were placed in the tumour area with the highest radioactivity concentration and their respective standardised uptake values (SUV) were recorded. Results: All tumours were detected and categorised as adrenocortical by MTO-PET. SUVhs as well as SUVmax were higher in PA compared to non-functional adenomas. Normal adrenal cortex was suppressed after dexamethasone (p<0.05) but tumour SUV was not significantly decreased after suppression in either PA or non-functional tumours (p>0.05). However, these changes caused no significant increase in the tumour-to-normal adrenal ratio (p>0.05). Conclusion: MTO-PET is a highly sensitive method for detecting and categorising even small adrenocortical tumours in PA. In this series dexamethasone-suppressed MTO-PET was ubable to increase the tumour-to-normal-adrenal ratio to further facilitate detection of small adenomas in PA as an alternative to adrenal venous sampling.
Keyword
- Metomidate
- PET
- Primary aldosteronism
- Dexamethasone
- Adrenal
- Suppression
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database